Morning Movers
Watch us on YouTube Live at 8:30AM EST

BBY.NY -11.38%
Best Buy Co Inc – Forecast fourth-quarter comparable sales below analysts’ estimates, as the electronics retailer braces for a hit from likely product shortages during the crucial holiday shopping season and higher shipping costs. Reported Earnings per share of $2.08 adjusted vs. $1.91 expected on revenue of $11.91 billion vs. $11.58 billion expected.

ZM.NQ -8.78%
Zoom Video Communications – Shares are set to open at their lowest level in over a year even as the one time pandemic darling reported Q3 revenue of $1.05 bln, beating analysts’ estimates of $1.02 bln. ZM also raised its full-year revenue forecast to about $4.08 bln from $4.01 bln, above analysts’ estimates of $4.05 bln. Shares are lower as caution returns to high growth stocks.

XPEV.NY 3.61%
Xpeng Inc – The Chinese EV maker is sharply higher in early trading after reporting Q3 deliveries growth of 199% Y/Y and 47.5% Q/Q to 25,666 units, exceeding the company’s guidance of 23,000 to 25,000 vehicles. Revenues from vehicle sales increased 187.7% to $847.4M, mainly due to higher vehicle delivery, especially for the P7. Revenues from services and others grew 182.2% to $40.3M. The company also increased its Q4 guidance.

AAPL.NQ 0.03%
Apple Inc – Back on watch after holding up the entire market yesterday trading back to fresh all-time-highs. The rally followed last week’s Apple Car update, share are modestly lower premarket however after Italy announced it would fine both Apple and Amazon $225m in the latest anti-trust suit to go against the tech giants.

TSLA.NQ 1.26%
Tesla Inc – Higher premarket for the third straight session coming off a solid performance Monday while the rest of the Nasdaq was under pressure. The company officially said it will begin delivering its performance Model Y edition in China soon after CEO Elon Musk said on Twitter the Model S Plaid could be in China as soon as March over the weekend.

ISPC.NQ 95.27%
Ispecimen Inc – The micro cap biotech company is back on watch actively traded premarket extending gains for a second day. The stock more than doubled Monday, in its best day ever day, after the online marketplace for human biospecimens secured contracts with the U.S. govt for COVID-19 research. Some other biotech cos that also jumped despite no apparent news: Longeveron LGVN extended its recent sharp rally. LGVN

DKS.NY -2.34%
DICK’S Sporting Goods Inc – Reported record third quarter sales and earnings delivering a 12.2% increase in same store sales and also raised its full year guidance – Q3 earnings per diluted share of $2.78 and non-GAAP earnings per diluted share of $3.19, up 51% and 59% respectively easily topped estimates. The sporting goods retailer raised its full year 2021 earnings forecast per diluted share to $12.88 to 13.06 and raises its full year 2021 non-GAAP earnings per diluted share guidance to $14.60 to 14.80.

QLGN.NQ 73.60%
Qualigen Therapeutics – Another micro cap biotech rallying on little to no news with high social media chatter. $36m market cap, 26m free float.

PTPI.NQ 96.99%
Petros Pharmaceuticals – $17m market cap, 6.6m free float. No news. Increased online, retail interest.

KTTA.NQ 186.00%
Pasithea Therapeutics – $29m market cap 5.5m free float. No news. Increased online, retail interest.

Leave a Reply

Your email address will not be published.